Server:Apache...
X-Powered-By:PHP/5.5.38
The main IP address: 217.160.123.17,Your server Germany,Karlsruhe ISP:1&1 Internet AG TLD:com CountryCode:DE
The description :home obesity about the team jobs news contact log in lean genes allowed you to eat without gaining weight. nature did it, obetherapy can reproduce it. read more obetherapy is a french start-up biotech...
This report updates in 16-Jun-2018
Created Date: | 2001-04-12 |
Changed Date: | 2017-04-13 |
Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host obetherapy.com. Currently, hosted in Germany and its service provider is 1&1 Internet AG .
Latitude: | 49.004718780518 |
Longitude: | 8.3858299255371 |
Country: | Germany (DE) |
City: | Karlsruhe |
Region: | Baden-Wurttemberg |
ISP: | 1&1 Internet AG |
HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache containing the details of what the browser wants and will accept back from the web server.
X-Powered-By: | PHP/5.5.38 |
Transfer-Encoding: | chunked |
Content-Encoding: | gzip |
Keep-Alive: | timeout=15 |
Server: | Apache |
Connection: | keep-alive |
Link: | |
Date: | Sat, 16 Jun 2018 05:39:43 GMT |
Content-Type: | text/html; charset=UTF-8 |
X-Pingback: | http://obetherapy.com/xmlrpc.php |
soa: | ns1101.ui-dns.biz. hostmaster.1and1.fr. 2016071500 28800 7200 604800 600 |
ns: | ns1101.ui-dns.biz. ns1101.ui-dns.de. ns1101.ui-dns.org. ns1101.ui-dns.com. |
mx: | MX preference = 10, mail exchanger = mx01.1and1.fr. MX preference = 10, mail exchanger = mx00.1and1.fr. |
ipv4: | IP:217.160.123.17 ASN:8560 OWNER:ONEANDONE-AS Brauerstrasse 48, DE Country:DE |
ipv6: | 2001:8d8:1001:9d:abf9:8007:1d7c:9041//8560//ONEANDONE-AS Brauerstrasse 48, DE//DE |
home obesity about the team jobs news contact log in lean genes allowed you to eat without gaining weight. nature did it, obetherapy can reproduce it. read more obetherapy is a french start-up biotech company dedicated to the discovery of new targets and the development of new drugs for obesity, hypercholesterolemia and type ii diabetes based on lean and/or starvation phenotype. “research is to see what everybody else has seen, and to think what nobody else has thought.” albert szent-gyorgyi medecine nobel prize 1937 “the human mind treats a new idea the same way the body treats a strange protein; it rejects it.” peter medawar medecine nobel prize 1960 obetherapy’s international conferences participation – gwas : big data as a tool for metabolic syndrome study. lifescience r&d big data leaders forum basel, switzerland december 3-5, 2013.). – thinking outside the box : for the identification of novel targets for diabetes treatment. 1st october to 2nd october 2013, london, united kingdom. – enteropeptidase: identifying and validating a novel target for the treatment obesity and type ii diabetes by rational drug design. 24-27th 9th idf-wpr congress & 4th aasd scientific meeting, kyoto, japan 2012(selected from abstract 15min). – thinking outside the box: for the identification of novel targets for diabetes treatment. 6th annual diabetes conference evaluating the latest developments in managing diabetes and secondary complications in cardiovascular pathology. 25th – 26th april 2012, thistle city barbican, london, uk – thinking outside the box: considering new avenues of drug development that might lead to a breakthroughs in diabetes treatments. clinical trial trials in diabetes 28-29 february 2012, arena, amsterdam, holland – enteropeptidase: a gene associated with a lean human phenotype as a novel target for the treatment of obesity and type ii diabetes. emerging therapeutic strategies for metabolic disorders 10th to 11th november 2010, copthorne tara hotel, london, united kingdom. (chairman of the conference) – enteropeptidase: a gene associated to a lean human phenotype as a novel target for the treatment obesity and type ii diabetes.diabetes drug discovery, targeting diabetes with novel therapeutics world trade center, novemeber 3rd and 4th 2010 boston, us – identification of new target for obesity and type ii diabetes treatment based on genes associated with lean phenotype in human. drug discovery & development conference 2010, wdd european summit 26-27th october scandic hotel copenhagen, denmark – identification of new target for obesity and type ii diabetes treatment based on genes associated with lean phenotype in human. the 6th international congress of pathophysiology, palais des congré montreal, canada, 22-25 september 2010. (selected from abstract). – identification of new target for obesity and typeii diabetes treatment based on genes associated with lean phenotype….idof 2010 when science meets health cares. 21-23 october 2010 hilton athens greece.(selected from abstract). – identification of new target for obesity and type ii diabetes treatment based on genes associated with lean phenotype in human and validation of the target by gene inactivation in mice. the 3rd world congress on controversies to consensus in diabetes, obesity and hypertension (codhy) hilton hotel, prague, czech republic, may 13-16, 2010 (selected from abs look at obetherapy biotechnology presentation here ©2015 obetherapy biotechnology connect with us linkedin obetherapy biotechnology genopole industries 4 rue pierre fontaine 91000 evry website credits 25thfloor design büro image credits nhgri's digital media database
http://obetherapy.com/the-team
http://obetherapy.com//#masthead
http://obetherapy.com/
http://obetherapy.com/news-obetherapy
http://obetherapy.com/about-obetherapy
http://obetherapy.com/contact
http://obetherapy.com/jobs
http://obetherapy.com/obesity
http://obetherapy.com/wp-login.php
Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: OBETHERAPY.COM
Registry Domain ID: 69163991_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.1and1.com
Registrar URL: http://registrar.1and1.info
Updated Date: 2017-04-13T07:18:00Z
Creation Date: 2001-04-12T10:23:48Z
Registry Expiry Date: 2018-04-12T10:23:54Z
Registrar: 1&1 Internet SE
Registrar IANA ID: 83
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +1.6105601459
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS61.1AND1.FR
Name Server: NS62.1AND1.FR
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2017-08-23T00:24:15Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR 1&1 Internet SE
SERVERS
SERVER com.whois-servers.net
ARGS domain =obetherapy.com
PORT 43
TYPE domain
DOMAIN
NAME obetherapy.com
CHANGED 2017-04-13
CREATED 2001-04-12
STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
NS61.1AND1.FR 217.160.80.170
NS62.1AND1.FR 217.160.81.170
REGISTERED yes
The following list shows you to spelling mistakes possible of the internet users for the website searched .